Gluetacs Therapeutics jointly published an article in Journal of Biological Chemistry

ON：2023-05-17 TAG：GLUETACS THERAPEUTICS

PRESS RELEASE

Shanghai, China – 17 May 2023

Gluetacs Therapeutics jointly published an article in Journal of Biological Chemistry, reporting a new PROTAC inhibitor targeting tyrosine kinase FER, and exploring its mechanism of inhibiting ovarian cancer cell motility and invasiveness.

Article Link：https://www.jbc.org/article/S0021-9258(23)01853-7/fulltext